Sylvia Chien

577 total citations
25 papers, 366 citations indexed

About

Sylvia Chien is a scholar working on Hematology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Sylvia Chien has authored 25 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Molecular Biology and 6 papers in Immunology and Allergy. Recurrent topics in Sylvia Chien's work include Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (6 papers) and Cell Adhesion Molecules Research (6 papers). Sylvia Chien is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (6 papers) and Cell Adhesion Molecules Research (6 papers). Sylvia Chien collaborates with scholars based in United States, Panama and Japan. Sylvia Chien's co-authors include Pamela S. Becker, Elihu H. Estey, Vivian G. Oehler, Jin Dai, Timothy J. Martins, Chris P. Miller, C. Anthony Blau, Scott Lundberg, Benjamin A. Logsdon and Safiye Çelik and has published in prestigious journals such as Nature Communications, Blood and PLoS Computational Biology.

In The Last Decade

Sylvia Chien

24 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Chien United States 8 142 131 68 50 45 25 366
Zhiyao Zhang China 11 129 0.9× 163 1.2× 67 1.0× 24 0.5× 46 1.0× 43 315
Luke T. Dang United States 7 62 0.4× 254 1.9× 67 1.0× 43 0.9× 25 0.6× 11 470
Richard Schabath Germany 10 363 2.6× 134 1.0× 115 1.7× 95 1.9× 33 0.7× 17 562
Angela Schumich Austria 13 360 2.5× 131 1.0× 122 1.8× 64 1.3× 38 0.8× 24 623
Sonya M. Diakiw Australia 12 62 0.4× 188 1.4× 19 0.3× 34 0.7× 47 1.0× 18 546
Shike Wang China 9 20 0.1× 192 1.5× 159 2.3× 38 0.8× 66 1.5× 13 403
Mark Peek United States 9 105 0.7× 219 1.7× 60 0.9× 42 0.8× 50 1.1× 9 456
Cassandra M Kerr United States 12 331 2.3× 180 1.4× 39 0.6× 91 1.8× 53 1.2× 42 480
Timothy L. Chen United States 8 124 0.9× 333 2.5× 159 2.3× 39 0.8× 33 0.7× 10 449
Tamara K. Moyo United States 11 69 0.5× 143 1.1× 84 1.2× 30 0.6× 79 1.8× 32 317

Countries citing papers authored by Sylvia Chien

Since Specialization
Citations

This map shows the geographic impact of Sylvia Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Chien more than expected).

Fields of papers citing papers by Sylvia Chien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Chien. The network helps show where Sylvia Chien may publish in the future.

Co-authorship network of co-authors of Sylvia Chien

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Chien. A scholar is included among the top collaborators of Sylvia Chien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Chien. Sylvia Chien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamath‐Loeb, Ashwini S., Jiang‐Cheng Shen, Michael Schmitt, et al.. (2022). Accurate detection of subclonal variants in paired diagnosis-relapse acute myeloid leukemia samples by next generation Duplex Sequencing. Leukemia Research. 115. 106822–106822. 4 indexed citations
2.
Hart, Matthew R., Donovan J. Anderson, Andriana G. Kotini, et al.. (2021). Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation. Blood Advances. 5(3). 687–699. 11 indexed citations
3.
Chien, Sylvia, et al.. (2021). Unsupervised discovery of dynamic cell phenotypic states from transmitted light movies. PLoS Computational Biology. 17(12). e1009626–e1009626. 4 indexed citations
4.
Coffey, David G., Andrew J. Cowan, Timothy J. Martins, et al.. (2021). High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma. JCO Precision Oncology. 5(5). 602–612. 11 indexed citations
5.
Qin, Guangrong, Ilya Shmulevich, Taek‐Kyun Kim, et al.. (2020). Co-Occurring Mutation Clusters Predict Drug Sensitivity in Acute Myeloid Leukemia. Blood. 136(Supplement 1). 12–13.
6.
Halpern, Anna B., Timothy J. Martins, Erica C. Jonlin, et al.. (2020). Case of Chemotherapy-Refractory, RAS-Mutated Chronic Myelomonocytic Leukemia Responsive to Single-Agent Trametinib Based on Results From a High-Throughput Drug Screen. JCO Precision Oncology. 4(4). 1367–1373. 1 indexed citations
7.
Becker, Pamela S., Ted Gooley, Edward N. Libby, et al.. (2019). High Throughput Drug Synergy Testing in a Clinical Trial of Panobinostat, Carfilzomib, Dexamethasone to Define Response Biomarkers for Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 1902–1902. 2 indexed citations
8.
Coffey, David G., Andrew J. Cowan, Damian J. Green, et al.. (2019). High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 1885–1885. 1 indexed citations
9.
Chien, Sylvia, James Annis, Jin Dai, et al.. (2018). High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 180–180. 3 indexed citations
10.
Chien, Sylvia, Jin Dai, John L. Magnani, et al.. (2018). E-Selectin Ligand Expression By Leukemic Blasts Is Associated with Prognosis in Patients with AML. Blood. 132(Supplement 1). 1513–1513. 5 indexed citations
11.
Lee, Su‐In, Safiye Çelik, Benjamin A. Logsdon, et al.. (2017). A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nature Communications. 9(1). 42–42. 192 indexed citations
12.
13.
Becker, Pamela S., Vivian G. Oehler, Elihu H. Estey, et al.. (2014). Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay. Blood. 124(21). 3748–3748. 1 indexed citations
14.
Chien, Sylvia, Matthew Pawlus, Randall T. Moon, et al.. (2013). Adhesion Of Acute Myeloid Leukemia Blasts To E-Selectin In The Vascular Niche Enhances Their Survival By Mechanisms Such As Wnt Activation. Blood. 122(21). 61–61. 31 indexed citations
15.
Chien, Sylvia, Brent L. Wood, Elihu H. Estey, et al.. (2013). Mobilization Of Blasts and Leukemia Stem Cells by Anti-CXCR4 Antibody BMS-936564 (MDX 1338) in Patients With Relapsed/Refractory Acute Myeloid Leukemia. Blood. 122(21). 3882–3882. 9 indexed citations
16.
Adair, Jennifer E., Xin Zhao, Sylvia Chien, et al.. (2012). Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities. Journal of Molecular Medicine. 90(11). 1283–1294. 5 indexed citations
17.
Chien, Sylvia, Xin Zhao, Thalia Papayannopoulou, Frederick R. Appelbaum, & Pamela S. Becker. (2011). The CXCR4 Inhibitor Plerixafor Effectively Mobilizes Primary AML in NODscid IL2Rγc−/− Xenografts and Markedly Reduces but Does Not Eradicate Leukemia in Combination with Cytarabine +/− Clofarabine Chemotherapy. Blood. 118(21). 1432–1432. 1 indexed citations
18.
19.
Becker, Pamela S., Sylvia Chien, Mikhail Roshal, et al.. (2009). Adhesion Receptor Expression by Acute Myeloid Leukemia (AML) Bone Marrow Derived or Circulating Blasts and AML Stem Cells: The Key to Overcoming Chemoresistance.. Blood. 114(22). 2658–2658. 2 indexed citations
20.
Richard, Robert E., R. Angelo de Claro, James Yan, et al.. (2004). Differences in F36VMpl-Based in Vivo Selection among Large Animal Models. Molecular Therapy. 10(4). 730–740. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiyao Zhang Breakdown of academic impact, for papers by Luke T. Dang Breakdown of academic impact, for papers by Richard Schabath Breakdown of academic impact, for papers by Angela Schumich Breakdown of academic impact, for papers by Sonya M. Diakiw Breakdown of academic impact, for papers by Shike Wang Breakdown of academic impact, for papers by Mark Peek Breakdown of academic impact, for papers by Cassandra M Kerr Breakdown of academic impact, for papers by Timothy L. Chen Breakdown of academic impact, for papers by Tamara K. Moyo
Rankless by CCL
2026